Roosevelt Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $355K | Hold |
7,136
| – | – | 0.03% | 209 |
|
|
2022
Q2 | $398K | Hold |
7,136
| – | – | 0.03% | 194 |
|
|
2022
Q1 | $396K | Sell |
7,136
-240
| -3% | -$12.3K | 0.02% | 207 |
|
|
2021
Q4 | $413K | Buy |
7,376
+120
| +2% | +$6.5K | 0.02% | 203 |
|
|
2021
Q3 | $348K | Hold |
7,256
| – | – | 0.02% | 206 |
|
|
2021
Q2 | $304K | Sell |
7,256
-600
| -8% | -$23.3K | 0.02% | 213 |
|
|
2021
Q1 | $265K | Sell |
7,856
-400
| -5% | -$14.2K | 0.02% | 218 |
|
|
2020
Q4 | $288K | Sell |
8,256
-250
| -3% | -$8.64K | 0.02% | 197 |
|
|
2020
Q3 | $295K | Buy |
8,506
+250
| +3% | +$8.33K | 0.02% | 178 |
|
|
2020
Q2 | $270K | Buy |
8,256
+286
| +4% | +$9.13K | 0.03% | 143 |
|
|
2020
Q1 | $240K | Sell |
7,970
-1,000
| -11% | -$29.8K | 0.03% | 137 |
|
|
2019
Q4 | $260K | Sell |
8,970
-2,690
| -23% | -$74.5K | 0.03% | 137 |
|
|
2019
Q3 | $301K | Buy |
11,660
+540
| +5% | +$13.7K | 0.03% | 128 |
|
|
2019
Q2 | $284K | Sell |
11,120
-3,000
| -21% | -$74.1K | 0.03% | 125 |
|
|
2019
Q1 | $369K | Hold |
14,120
| – | – | 0.05% | 116 |
|
|
2018
Q4 | $325K | Hold |
14,120
| – | – | 0.04% | 156 |
|
|
2018
Q3 | $333K | Hold |
14,120
| – | – | 0.03% | 127 |
|
|
2018
Q2 | $326K | Sell |
14,120
-1,858
| -12% | -$44.2K | 0.03% | 125 |
|
|
2018
Q1 | $393K | Sell |
15,978
-2,650
| -14% | -$69.6K | 0.04% | 127 |
|
|
2017
Q4 | $500K | Hold |
18,628
| – | – | 0.05% | 135 |
|
|
2017
Q3 | $448K | Sell |
18,628
-622
| -3% | -$14.1K | 0.04% | 144 |
|
|
2017
Q2 | $413K | Sell |
19,250
-4,450
| -19% | -$89.8K | 0.04% | 151 |
|
|
2017
Q1 | $406K | Sell |
23,700
-12,112
| -34% | -$211K | 0.04% | 158 |
|
|
2016
Q4 | $642K | Sell |
35,812
-126,450
| -78% | -$2.29M | 0.06% | 131 |
|
|
2016
Q3 | $3.37M | Sell |
162,262
-461,446
| -74% | -$11.4M | 0.27% | 84 |
|
|
2016
Q2 | $16.8M | Sell |
623,708
-51,264
| -8% | -$1.41M | 1.3% | 30 |
|
|
2016
Q1 | $18.3M | Sell |
674,972
-152,612
| -18% | -$4.09M | 1.63% | 22 |
|
|
2015
Q4 | $24M | Buy |
+827,584
| New | +$22.9M | 1.58% | 23 |
|
|
2015
Q3 | – | Sell |
-827,952
| Closed | -$22.7M | – | 227 |
|
|
2015
Q2 | $22.7M | Buy |
827,952
+50,738
| +7% | +$1.43M | 1.34% | 27 |
|
|
2015
Q1 | $20.7M | Buy |
777,214
+20,782
| +3% | +$479K | 1.13% | 35 |
|
|
2014
Q4 | $16M | Buy |
756,432
+69,954
| +10% | +$1.56M | 0.89% | 38 |
|
|
2014
Q3 | $16.3M | Buy |
686,478
+75,578
| +12% | +$1.74M | 0.87% | 36 |
|
|
2014
Q2 | $14.1M | Sell |
610,900
-29,908
| -5% | -$660K | 0.6% | 40 |
|
|
2014
Q1 | $14.6M | Buy |
640,808
+7,338
| +1% | +$156K | 0.68% | 40 |
|
|
2013
Q4 | $11.7M | Buy |
633,470
+1,490
| +0.2% | +$26K | 0.53% | 44 |
|
|
2013
Q3 | $10.7M | Sell |
631,980
-49,600
| -7% | -$834K | 0.48% | 46 |
|
|
2013
Q2 | $10.6M | Buy |
+681,580
| New | +$11.3M | 0.47% | 48 |
|
Other funds holding NVO
F
Roosevelt Investment Group's NVO Position: Q3 2022 in Review
Roosevelt Investment Group held its Novo Nordisk (NVO) position steady in Q3 2022 at 7,136 shares worth $355K. The position accounts for 0.03% of the portfolio, ranked #209.
Roosevelt Investment Group first reported a position in NVO in Q2 2013 and has held it in 37 quarters since. The position peaked at $24M in Q4 2015. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.
- Roosevelt Investment Group held 7,136 shares of Novo Nordisk worth $355K as of Q3 2022.
- Roosevelt Investment Group left its Novo Nordisk share count unchanged in Q3 2022.
- Novo Nordisk made up 0.03% of Roosevelt Investment Group's portfolio in Q3 2022, its #209 holding.
- Roosevelt Investment Group first reported a position in Novo Nordisk in Q2 2013 and has held it in 37 quarters since.
- Roosevelt Investment Group's Novo Nordisk position peaked at $24M in Q4 2015.
- 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.
Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.